In our study, we investigated the relationship between breast cancer risk and genetic variations in DNA repair [XRCC3 Thr241Met and XRCC4 G(‐1394) T] and apoptosis [BAX G(-248) A and BCL-2 C(‐938) A] pathways. This evidence concerns the gene BCL2 and breast carcinoma.